Status:
COMPLETED
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the side effects of radiation treatment and surgery versus radiation alone, where no surgery is done to move the salivary gland and place it under the chin regi...
Eligibility Criteria
Inclusion
- Patients with a histological diagnosis of squamous cell carcinoma
- Patients with unilateral or no neck involvement of the nasopharynx
- The submandibular transfer will be done on the uninvolved side of the neck.
- Karnofsky score greater than or equal to 70
- Expected survival greater than one year
- A signed informed consent
Exclusion
- Bilateral neck nodes involvement. Involvement of level 1 lymph nodes on the side of the proposed procedure.
Key Trial Info
Start Date :
July 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00168116
Start Date
July 1 2000
End Date
June 1 2009
Last Update
February 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2